Philip Van Kerrebroeck

21.4k total citations · 5 hit papers
104 papers, 15.8k citations indexed

About

Philip Van Kerrebroeck is a scholar working on Urology, Rheumatology and Epidemiology. According to data from OpenAlex, Philip Van Kerrebroeck has authored 104 papers receiving a total of 15.8k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Urology, 72 papers in Rheumatology and 28 papers in Epidemiology. Recurrent topics in Philip Van Kerrebroeck's work include Urinary Bladder and Prostate Research (92 papers), Pelvic floor disorders treatments (67 papers) and Urinary Tract Infections Management (28 papers). Philip Van Kerrebroeck is often cited by papers focused on Urinary Bladder and Prostate Research (92 papers), Pelvic floor disorders treatments (67 papers) and Urinary Tract Infections Management (28 papers). Philip Van Kerrebroeck collaborates with scholars based in Netherlands, United Kingdom and United States. Philip Van Kerrebroeck's co-authors include Paul Abrams, Linda Cardozo, Derek Griffiths, Alan Wein, Peter Rosier, U. Ulmsten, Arne Victor, Magnus Fall, Anders Mattiasson and Arthur M. Sterling and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Obstetrics and Gynecology.

In The Last Decade

Philip Van Kerrebroeck

99 papers receiving 15.3k citations

Hit Papers

The standardisation of terminology of lower urinary tract... 2002 2026 2010 2018 2002 2003 2002 2002 2002 2.0k 4.0k 6.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip Van Kerrebroeck Netherlands 36 12.9k 12.5k 5.4k 4.0k 1.7k 104 15.8k
Linda Cardozo United Kingdom 49 12.8k 1.0× 14.3k 1.1× 6.3k 1.2× 5.1k 1.3× 1.2k 0.7× 326 17.5k
Peter Rosier Netherlands 23 9.5k 0.7× 9.5k 0.8× 4.0k 0.7× 2.9k 0.7× 1.3k 0.8× 111 11.7k
Alan Wein United States 16 8.1k 0.6× 8.5k 0.7× 3.6k 0.7× 2.6k 0.7× 1.1k 0.6× 24 10.3k
Marcus J. Drake United Kingdom 49 6.8k 0.5× 5.2k 0.4× 2.2k 0.4× 1.8k 0.4× 1.8k 1.1× 290 9.1k
Zoë Kopp United States 39 7.5k 0.6× 7.0k 0.6× 4.3k 0.8× 1.3k 0.3× 899 0.5× 82 9.0k
Jean‐Jacques Wyndaele Belgium 43 4.9k 0.4× 3.9k 0.3× 2.2k 0.4× 1.1k 0.3× 428 0.3× 231 6.5k
Søren Rittig Denmark 41 4.7k 0.4× 2.8k 0.2× 1.7k 0.3× 882 0.2× 1.1k 0.6× 199 7.5k
Alan J. Wein United States 32 3.8k 0.3× 3.9k 0.3× 1.9k 0.3× 1.5k 0.4× 1.1k 0.6× 163 6.2k
Jens Peter Nørgaard Denmark 35 3.0k 0.2× 1.4k 0.1× 904 0.2× 604 0.2× 792 0.5× 108 4.1k
Hunter Wessells United States 48 3.6k 0.3× 1.4k 0.1× 192 0.0× 3.3k 0.8× 531 0.3× 196 6.6k

Countries citing papers authored by Philip Van Kerrebroeck

Since Specialization
Citations

This map shows the geographic impact of Philip Van Kerrebroeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Van Kerrebroeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Van Kerrebroeck more than expected).

Fields of papers citing papers by Philip Van Kerrebroeck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Van Kerrebroeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Van Kerrebroeck. The network helps show where Philip Van Kerrebroeck may publish in the future.

Co-authorship network of co-authors of Philip Van Kerrebroeck

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Van Kerrebroeck. A scholar is included among the top collaborators of Philip Van Kerrebroeck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Van Kerrebroeck. Philip Van Kerrebroeck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Digesu, Alex, Philip Van Kerrebroeck, Sohier Elneil, et al.. (2022). Patient‐tailored healthcare and tibial nerve neuromodulation in the treatment of patients with overactive bladder symptoms. Neurourology and Urodynamics. 41(2). 679–684. 4 indexed citations
2.
McCrery, Rebecca, Felicia Lane, Chris Taylor, et al.. (2021). Two‐year outcomes of the ARTISAN‐SNM study for the treatment of urinary urgency incontinence using the Axonics rechargeable sacral neuromodulation system. Neurourology and Urodynamics. 40(2). 714–721. 15 indexed citations
3.
Dudding, T. C., Paul‐Antoine Lehur, Emmanuel Chartier‐Kastler, et al.. (2021). Reprogramming Sacral Neuromodulation for Sub-Optimal Outcomes: Evidence and Recommendations for Clinical Practice. Neuromodulation Technology at the Neural Interface. 24(7). 1247–1257. 13 indexed citations
4.
McCrery, Rebecca, Chris Taylor, Osvaldo Padron, et al.. (2020). One‐year outcomes of the ARTISAN‐SNM study with the Axonics System for the treatment of urinary urgency incontinence. Neurourology and Urodynamics. 39(5). 1482–1488. 20 indexed citations
5.
Everaert, Karel, François Hervé, Ruud Bosch, et al.. (2019). International Continence Society consensus on the diagnosis and treatment of nocturia. Neurourology and Urodynamics. 38(2). 478–498. 82 indexed citations
6.
Digesu, Alex, Sohier Elneil, John Heesakkers, & Philip Van Kerrebroeck. (2018). A prospective, multicenter, international clinical trial to assess the efficacy and safety of a novel wireless implantable tibial nerve stimulator for the treatment of patients with refractory overactive bladder (OAB): 3-years results. Neurourology and Urodynamics. 1 indexed citations
7.
Blok, Bertil, Philip Van Kerrebroeck, Stefan De Wachter, et al.. (2018). Three month clinical results with a rechargeable sacral neuromodulation system for the treatment of overactive bladder. Neurourology and Urodynamics. 37(S2). S9–S16. 23 indexed citations
8.
Oelke, Matthias, Stefan De Wachter, Marcus J. Drake, et al.. (2017). A practical approach to the management of nocturia. International Journal of Clinical Practice. 71(11). e13027–e13027. 61 indexed citations
9.
Marcelissen, Tom, et al.. (2017). Optimal Lead Positioning in Sacral Neuromodulation: Which Factors Are Related to Treatment Outcome?. Neuromodulation Technology at the Neural Interface. 20(8). 830–835. 13 indexed citations
10.
Kerrebroeck, Philip Van, François Haab, J.C. Angulo, et al.. (2013). Efficacy and Safety of Solifenacin Plus Tamsulosin OCAS in Men with Voiding and Storage Lower Urinary Tract Symptoms: Results from a Phase 2, Dose-finding Study (SATURN). European Urology. 64(3). 398–407. 50 indexed citations
11.
Νitti, Victor W., Sender Herschorn, Vikram Khullar, et al.. (2012). Efficacy of mirabegron in patients with overactive bladder (OAB): Pre-specified analysis of three randomised, double-blind, placebo-controlled, Phase III studies. Neurourology and Urodynamics. 4 indexed citations
12.
Khullar, Vikram, J. Cambronero, J.C. Angulo, et al.. (2012). Age-related efficacy of the selective ß3-adrenoceptor agonist mirabegron for the treatment of overactive bladder (OAB): pooled analysis of three prospective, randomised Phase III studies in patients aged >= 65 years. 8 indexed citations
13.
Kerrebroeck, Philip Van, Hashim Hashim, Tove Holm‐Larsen, Dudley Robinson, & Neil Stanley. (2010). Thinking beyond the bladder: antidiuretic treatment of nocturia. International Journal of Clinical Practice. 64(6). 807–816. 32 indexed citations
14.
Renterghem, Koenraad van, Gommert A. van Koeveringe, Ruth Achten, & Philip Van Kerrebroeck. (2009). A new algorithm in patients with elevated and/or rising prostate-specific antigen level, minor lower urinary tract symptoms, and negative multisite prostate biopsies. International Urology and Nephrology. 42(1). 29–38. 8 indexed citations
15.
Renterghem, Koenraad van, Gommert A. van Koeveringe, Ruth Achten, & Philip Van Kerrebroeck. (2009). Long-Term Clinical Outcome of Diagnostic Transurethral Resection of the Prostate in Patients with Elevated Prostate-Specific Antigen Level and Minor Lower Urinary Tract Symptoms. Urologia Internationalis. 83(1). 60–65. 8 indexed citations
16.
Kerrebroeck, Philip Van, Masoumeh Rezapour, A. Cortesse, et al.. (2007). Desmopressin in the Treatment of Nocturia: A Double-Blind, Placebo-Controlled Study. European Urology. 52(1). 221–229. 104 indexed citations
17.
Chapple, Christopher R., Philip Van Kerrebroeck, Andrea Tubaro, et al.. (2007). 1188: Efficacy of Fesoterodine in Patients with Overactive Bladder (OAB): Improvements in OAB Symptoms and Health-Related Quality of Life (HRQL). The Journal of Urology. 177(4S). 392–392. 1 indexed citations
18.
Artibani, Walter, Linda Cardozo, David Castro‐Díaz, et al.. (2006). Design and Validation of a New Screening Instrument for Lower Urinary Tract Dysfunction: The Bladder Control Self-Assessment Questionnaire (B-SAQ). European Urology. 52(1). 230–238. 38 indexed citations
19.
Abrams, Paul, G. Amarenco, August Bakke, et al.. (2003). Tamsulosin: Efficacy and Safety in Patients With Neurogenic Lower Urinary Tract Dysfunction Due to Suprasacral Spinal Cord Injury. The Journal of Urology. 170(4 Part 1). 1242–1251. 76 indexed citations
20.
Lose, Gunnar, Othon Lalos, Robert Freeman, & Philip Van Kerrebroeck. (2003). Efficacy of desmopressin (Minirin) in the treatment of nocturia: a double-blind placebo-controlled study in women. American Journal of Obstetrics and Gynecology. 189(4). 1106–1113. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026